Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potential anticancer drug that selectively induces apoptosis in a variety of cancer cells by interacting with death receptors DR4 and DR5. TRAIL can also bind to decoy receptors (DcR1, DcR2, and osteoprotegerin receptor) that canno...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: van der Sloot, Almer M., Tur, Vicente, Szegezdi, Eva, Mullally, Margaret M., Cool, Robbert H., Samali, Afshin, Serrano, Luis, Quax, Wim J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: National Academy of Sciences 2006
Soggetti:
Biological Sciences
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1482632/
https://ncbi.nlm.nih.gov/pubmed/16731632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0510187103
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi